Barry Lederman

Barry Lederman is a prominent figure in the finance and investment sector, currently serving as the Chairman at Jonathan Partners, Inc. His extensive background includes significant roles in various companies, particularly in financial leadership positions.

Professional Background

• Chairman at Jonathan Partners, Inc.: In this role, he oversees strategic initiatives and company operations, leveraging his extensive experience in finance and management.
• Previous Roles: Lederman has held several high-profile positions including:
  • Chief Financial Officer (CFO) at Worldwide Clinical Trials (2022 - Present), where he manages financial operations and strategy.
  • CFO at Perimeter Solutions (2019 - 2022), successfully leading the company through an IPO on the NYSE.
  • CFO at Halo Pharmaceutical, Inc. (2015 - 2019), where he played a key role in the company's acquisition by Cambrex for $425 million.
  • He has also served as CFO in other notable organizations like Eisai and Wedgewood Pharmacy, managing large teams and complex financial operations across various sectors including pharmaceuticals and private equity.123

Education

Barry Lederman holds an impressive educational background:

• MBA from the University of Rochester - Simon Business School.
• Bachelor of Science in Electrical Engineering from the University of Rochester.
• Additional executive education from prestigious institutions such as Columbia Business School and The Wharton School, focusing on leadership, strategic finance, and mergers & acquisitions.23

Skills and Expertise

Lederman is known for his expertise in:

• Financial management and strategy.
• Mergers and acquisitions.
• Leading companies through IPOs and significant financial transitions.
• Managing complex financial operations within large organizations.123

His career reflects a commitment to excellence in financial leadership, making him a respected figure in his field.